Skip to main content

Innovative cancer treatment may sometimes cause cancer, FDA says

By The New York Times  
   November 29, 2023

CAR-T was first approved in 2017 for life-threatening blood cancers. The FDA says it had received 19 reports of new blood cancers in patients who received the treatment.

Full story

Get the latest on healthcare leadership in your inbox.